| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.089 | 0.6 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |